References
- Allen R, O’Brien BM. 2009. Uses of misoprostol in obstetrics and gynecology. Reviews in Obstetrics and Gynecology 2:159–168.
- Dal Monte A, Donzelli O. 1987. Tibial lengthening according to Ilizarov in congenital hypoplasia of the leg. Journal of Pediatric Orthopaedics 7:135–138.
- da Silva Dal Pizzol T, Knop FP, Mengue SS. 2006. Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta-analysis. Reproductive Toxicology 22:666–671.
- Graf WD, Shepard TH. 1997. Uterine contraction in the development of Möbius syndrome. Journal of Child Neurology 12:225–227.
- Marchese JW, Mullen MG, Doherty JH. Jr. 2012. Proximal femoral focal deficiency and fibular hemimelia associated with misoprostol use: a case report. Clinical Dysmorphology 21:229–230.
- Monteagudo A, Dong R, Timor-Tritsch IE. 2006. Fetal fibular hemimelia: case report and review of the literature. Journal of Ultrasound in Medicine 25:533–537.
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. 1981. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics 30:239–245.
- Philip NM, Shannon C, Winikoff B. 2002. Misoprostol and teratogenicity. Reviewing the evidence report of a meeting: Critical issues in reproductive health. New York: Population Council.
- The use of the WHO-UMC system for standardized case causality assessment; [cited 2015 Jul 01]. Available from: http://who-umc.org/Graphics/24734.pdf.
- Uffelman J, Woo R, Richards DS. 2000. Prenatal diagnosis of bilateral fibular hemimelia. Journal of Ultrasound in Medicine 19:341–344.